Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
---|
12/05/2002 | US20020183512 Compounds for use in treatment of cancer |
12/05/2002 | US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
12/05/2002 | US20020183391 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
12/05/2002 | US20020183386 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
12/05/2002 | CA2448062A1 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
12/05/2002 | CA2443346A1 Anticholinergic compounds and methods of use |
12/05/2002 | CA2442212A1 N-benzyl-m-phenylenediamine derivatives and dyes containing said compounds |
12/04/2002 | EP1262473A1 Precursors for fragrant ketones and fragrant aldehydes |
12/04/2002 | EP1100769B1 Aminomethylcarboxylic acid derivatives |
12/04/2002 | CN1383423A 6-fluorobicyclo [3.1.0] hexame derivatives |
12/04/2002 | CN1382685A Process for preparing R-salbutamol tartrate |
12/03/2002 | US6489479 Process for the preparation of mixed anhydrides |
12/03/2002 | US6489352 Antiepileptic agents; nervous system disorders |
11/28/2002 | WO2002095393A2 Drug evolution: drug design at hot spots |
11/28/2002 | WO2002062871A3 Comonomer compositions for production of imide-containing polyamino acids |
11/28/2002 | US20020177600 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic |
11/28/2002 | DE10125451A1 New N-benzyl-m-phenylenediamine derivatives and physiologically-compatible, water-soluble salts are used in oxidative colorant for keratin fibers, especially human hair |
11/27/2002 | EP1260511A1 Process for the preparation of 5-chloro-1-(4-fluorophenyl)-3-(1,2,3,6-tetrahydropyridin-4-yl)indole and method of manufacturing sertindole |
11/27/2002 | EP1260270A1 Preparation and use of palladium catalysts for cross coupling reactions |
11/27/2002 | EP1259470A2 A group of anti-cancer compounds with specific structure and their production method |
11/27/2002 | CN1382139A Method and intermediate for preparing is-a-oxazole formylamine and its analogue |
11/27/2002 | CN1382118A Biocyclic amino acids aspharmaceutical agents |
11/26/2002 | US6485799 Aniline derivatives, liquid-crystal composition containing the same, and liquid-crystal display element |
11/26/2002 | US6485629 Process for separation of heavy metals from residues by use of ethylene-diamine-disuccinic acid (edds) complexant |
11/26/2002 | CA2130333C Process for preparing .beta.-phenylisoserine and analogues thereof |
11/26/2002 | CA2060330C Compositions and method for soft tissue tumors |
11/24/2002 | CA2354921A1 Drug evolution: drug design at hot spots |
11/21/2002 | WO2002092550A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii |
11/21/2002 | WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
11/21/2002 | WO2002053528A8 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
11/21/2002 | US20020173494 Ammonium salts of inositol hexaphosphate, and uses thereof |
11/21/2002 | US20020173421 Cross-coupling reaction using palladium complex catalyst |
11/21/2002 | DE10123884A1 Preparation of palladium catalyst solution or dispersion involves reacting chloro-, bromo- or iodo-aromatic or aryl sulfonate, phosphine or diphosphine ligand and palladium salt |
11/21/2002 | CA2446747A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii |
11/21/2002 | CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
11/20/2002 | EP1257541A2 Polypharmacophoric agents |
11/20/2002 | EP1257524A1 A process for the preparation of salts of l-carnitine and alkanoyl l-carnitine with mucic acid |
11/20/2002 | EP1257523A1 Method of producing 3-aminoalkanoic acid esters |
11/20/2002 | EP0721936B1 Liquid softener composition and quaternary ammonium salt |
11/19/2002 | US6482943 Quinones as disease therapies |
11/19/2002 | US6482855 Oxidation resistance; stress relieving |
11/19/2002 | US6482849 Inhibitors of α4β1 mediated cell adhesion |
11/19/2002 | CA2243544C 7-amino-2-heptenoates and their use in the preparation of methylphenidate |
11/14/2002 | WO2002090318A1 Process for preparing bicyclic amino acids |
11/14/2002 | WO2002090313A1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies |
11/14/2002 | US20020169336 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
11/14/2002 | US20020169311 Generation of betaine, erythritol, inositol, sucrose, mannitol, glycerol and amino acids or mixtures; obtain mixture, apply to chromatographic column, elute preferential products form column |
11/14/2002 | US20020169208 Oxybutynin analogs; antichloinergic agents; side effect reduction; short half-life; water-soluble metabolites; incontinence; mydriatic and bronchodilator agents; respiratory system disorders; antiperspirants |
11/14/2002 | US20020169197 Diaryl-enynes |
11/14/2002 | US20020169192 Peroxisome proliferator activator receptor (PPAR); amino-ethyl- phenyl derivatives |
11/14/2002 | US20020168244 Locking nut, bolt and clip systems and assemblies |
11/13/2002 | EP1256568A1 Intermediates for the preparation of enantiomerically pure cyclopentane and cyclopentene beta amino acids |
11/13/2002 | EP1256342A1 Hypoglycemics comprising organic zinc (ii) complexes |
11/13/2002 | EP1255733A1 Farnesyl transferase inhibitors |
11/13/2002 | EP1255724A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
11/13/2002 | EP1255542A1 Substituted amino acids as neutral sphingomyelinase inhibitors |
11/13/2002 | EP0760658B1 Compounds for inhibiting osteoclast-mediated bone resorption |
11/13/2002 | CN1379779A Process for preparation of benzoxazine derivatives and intermediates therefor |
11/13/2002 | CN1379756A Substituted nor bornylamino derivatives, method for production thereof, use thereof as medicament or diagnostic reagent medicaments containing said compounds |
11/12/2002 | US6479700 Method for separating a basic amino acid from fermentation broth |
11/12/2002 | US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity |
11/12/2002 | US6479518 Zwitterionic tachykinin receptor antagonists |
11/12/2002 | CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists |
11/07/2002 | WO2002088068A1 Aminoacid-iodine complex |
11/07/2002 | WO2002088061A1 Novel atisane compound and use thereof |
11/07/2002 | WO2001047866A9 Substituted 1 and 2 naphthol mannich bases |
11/07/2002 | WO2001042243A3 Protein kinase inhibitors |
11/07/2002 | US20020165408 Industrial process for the production of L-carnitine |
11/07/2002 | US20020165282 PPAR agonists |
11/07/2002 | US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
11/07/2002 | US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
11/07/2002 | US20020165200 Central nervous system disorders |
11/06/2002 | EP1254883A1 Process for producing sobstituted 1,1,1-trifluoro-3-butene-2-ones |
11/06/2002 | EP1254092A1 Resolution of dl-racemic mixtures |
11/06/2002 | EP1124788A4 Bis(haloethyl)aminobenzene derivatives |
11/06/2002 | EP1012137B1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
11/06/2002 | EP1002020B1 Dye intermediate and method to manufacture dyes |
11/06/2002 | EP0975582B1 Preparation and use of iminodisuccinic acid salts |
11/06/2002 | EP0923528B1 Oligosaccharide synthesis |
11/06/2002 | EP0788473B1 Novel high enantio-selective process for producing pure enantiomeric cyclopentane and cyclopentene-beta-amino acids |
11/06/2002 | CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
11/06/2002 | CN1377881A Intermediate for preparing cascade polymeric ligand and contrast medium |
11/06/2002 | CN1093853C New method for preparing (S)-4-amino-hepta-5,6-dienoic acid and intermediate thereof |
11/06/2002 | CN1093755C Topical composition for inhibiting hair growth |
11/05/2002 | US6476243 Perfluorinated esters of alkanoyl L-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds |
11/05/2002 | US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity |
11/05/2002 | US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
11/05/2002 | CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments |
10/31/2002 | WO2002085877A2 Processes and intermediates for preparing benzyl substituted epoxides |
10/31/2002 | WO2002085839A1 Fused bicyclic or tricyclic amino acids |
10/31/2002 | WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
10/31/2002 | US20020161259 Catalyst comprising: a metal support comprising copper and a non-copper metal; and a copper-containing coating in specified amounts of copper; making N-(phosphonomethyl)glycine from monoethanolamine |
10/31/2002 | US20020161238 Novel methods for the preparation of taxanes using oxazolidine intermediates |
10/31/2002 | US20020161171 Comonomer compositions for production of imide-containing polyamino acids |
10/31/2002 | US20020161047 Method for preventing and treating visceral pain and gastrointestinal disorders |
10/31/2002 | US20020160962 Non-structural protein 3 (NS3), part of a hepatitis C virus protease necessary for polypeptide processing and viral replication; alpha-ketoamide compounds of given formula |
10/31/2002 | US20020158020 Process for the separation of organic substances from an aqueous mixture |
10/31/2002 | CA2445163A1 Processes and intermediates for preparing benzyl substituted epoxides |
10/30/2002 | EP1253138A2 Novel tertiary amine compounds having an ester structure and processes for preparing same |
10/30/2002 | EP1252133A2 Pharmaceutical compounds |